Perspective Therapeutics (CATX) Insider Trading & Ownership $3.68 -0.16 (-4.17%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$3.72 +0.03 (+0.95%) As of 08/1/2025 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Perspective Therapeutics (NYSE:CATX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.72%Number OfInsiders Buying(Last 12 Months)5Amount OfInsider Buying(Last 12 Months)$513.13KNumber OfInsiders Selling(Last 12 Months)0 Get CATX Insider Trade Alerts Want to know when executives and insiders are buying or selling Perspective Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CATX Insider Buying and Selling by Quarter Perspective Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/31/2025Robert F Williamson IIIDirectorBuy38,145$2.14$81,630.30 3/28/2025Johan M SpoorCEOBuy22,026$2.24$49,338.24 3/28/2025Juan GrahamCFOBuy33,333$2.25$74,999.25 3/28/2025Robert F Williamson IIIDirectorBuy22,192$2.27$50,375.84 12/4/2024Heidi HensonDirectorBuy25,975$3.85$100,003.75 12/4/2024Johan M SpoorCEOBuy8,000$3.77$30,160.00 11/25/2024Johan M SpoorCEOBuy14,500$3.78$54,810.00 11/25/2024Jonathan Robert HuntCFOBuy12,829$3.82$49,006.78 11/25/2024Robert F Williamson IIIDirectorBuy6,266$3.64$22,808.24 (Data available from 1/1/2013 forward) CATX Insider Trading Activity - Frequently Asked Questions Who is on Perspective Therapeutics' Insider Roster? The list of insiders at Perspective Therapeutics includes Heidi Henson, Johan M Spoor, Jonathan Robert Hunt, Juan Graham, Lantheus Alpha Therapy, Llc, Lori A Woods, Markus Puhlmann, and Robert F Williamson III. Learn more on insiders at CATX. What percentage of Perspective Therapeutics stock is owned by insiders? 3.72% of Perspective Therapeutics stock is owned by insiders. Learn more on CATX's insider holdings. Which Perspective Therapeutics insiders have been buying company stock? The following insiders have purchased CATX shares in the last 24 months: Heidi Henson ($100,003.75), Johan M Spoor ($251,308.24), Jonathan Robert Hunt ($134,164.78), Juan Graham ($74,999.25), Lantheus Alpha Therapy, Llc ($57,409,478.50), Lori A Woods ($99,988.70), Markus Puhlmann ($192,156.60), and Robert F Williamson III ($301,472.18). How much insider buying is happening at Perspective Therapeutics? Insiders have purchased a total of 6,323,329 CATX shares in the last 24 months for a total of $58,563,572.00 bought. Perspective Therapeutics Key ExecutivesMr. Johan M. Spoor (Age 52)CEO & Director Compensation: $855.78k1 recent tradesMr. Jonathan R. Hunt (Age 57)CFO and Principal Financial & Accounting Officer Compensation: $944.35kDr. Markus Puhlmann M.B.A. (Age 58)M.D., Chief Medical Officer Compensation: $633.14kMr. Shane CobbExecutive Vice President of OperationsDr. Michael K. Schultz Ph.D.Chief Science OfficerMr. Andrew BrightExecutive Vice President of BrachytherapyMr. Amos Hedt BAPGradDip, Chief Business Strategy OfficerDr. Frances L. Johnson M.D.Chief Innovation OfficerMr. David Hauser Ph.D.Senior Vice President of Clinical OperationsSteve KeefeSenior Vice President of Clinical Development More Insider Trading Tools from MarketBeat Related Companies BLFS Insider Selling TNDM Insider Selling PLSE Insider Selling MDXG Insider Selling SIBN Insider Selling IRMD Insider Selling EMBC Insider Selling BBNX Insider Selling AXGN Insider Selling AVNS Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NYSE:CATX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Perspective Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Perspective Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.